Zobrazeno 1 - 10
of 933
pro vyhledávání: '"carbapenem-resistant Enterobacterales"'
Autor:
Hongchen Zhang, Yue Wang, Xiaochen Zhang, Chenshan Xu, Dongchao Xu, Hongzhang Shen, Hangbin Jin, Jianfeng Yang, Xiaofeng Zhang
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 13, Iss 1, Pp 1-12 (2024)
Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) has become a routine endoscopic procedure that is essential for diagnosing and managing various conditions, including gallstone extraction and the treatment of bile duct and pa
Externí odkaz:
https://doaj.org/article/dd7c54c5d45740738475bd0baeb364b6
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3451-3462 (2024)
Ming Wei,1 Xi Chen,1 Jun Liu,1 Tianmeng Li,1 Peng Wang,1 Shuai Wang,1 Jing Wang,2,3 Li Gu1 1Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical Univers
Externí odkaz:
https://doaj.org/article/b64a7eef72d8447991feaefdc2255158
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 8, Pp 79-84 (2024)
Background: Worldwide, the emergence of carbapenem-resistant enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global concern to public health as they are responsible for several serious infections that lead to elevat
Externí odkaz:
https://doaj.org/article/b8b5c653d2c84490bb5e0473061f29df
Autor:
Olukemi Adekanmbi, Oluwafemi Popoola, Adeola Fowotade, Olusola Idowu, Babatunde Ogunbosi, Sulaiman Lakoh, Ini Adebiyi, Omobolaji Ayandipo, Ayodele Olukayode Iyun
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Carbapenem Resistant Enterobacterales (CRE) infections are increasingly associated with or directly responsible for morbidity and mortality from bacterial infections in sub-Saharan Africa where there are limited antibiotic options
Externí odkaz:
https://doaj.org/article/ce1879a26d2442bea5f4da2e06c2642d
Carbapenem-resistant Enterobacterales in wastewater resources and healthy carriers: A survey in Iran
Publikováno v:
Journal of Water and Health, Vol 22, Iss 6, Pp 1053-1063 (2024)
The carbapenem-resistant Enterobacterales (CRE) pose a pressing public health concern. Here, we investigated the frequency of CRE bacteria, carbapenemase-encoding genes, and the molecular epidemiology of carbapenemase-resistant Escherichia coli in wa
Externí odkaz:
https://doaj.org/article/9bbfe40d833148f8ad89f688e7844617
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 13, Iss 1, Pp 1-10 (2024)
Abstract Background Carbapenem-resistant E. coli (CREco) pose a significant public health threat due to their multidrug resistance. Colistin is often a last-resort treatment against CREco; however, the emergence of colistin resistance gene mcr-1 comp
Externí odkaz:
https://doaj.org/article/e2a8207017e541b59ceaa5ce668ac751
Autor:
Han W, Zhou P, Chen C, Wu C, Shen L, Wan C, Xiao Y, Zhang J, Wang B, Shi J, Yuan X, Gao H, Wang H, Zhou Y, Yu F
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 2541-2554 (2024)
Weihua Han,1,* Peiyao Zhou,2,* Chun Chen,3,* Chunyang Wu,2 Li Shen,1 Cailing Wan,4 Yanghua Xiao,4 Jiao Zhang,2 Bingjie Wang,1 Junhong Shi,1 Xinru Yuan,1 Haojin Gao,1 Hongxiu Wang,1 Ying Zhou,1 Fangyou Yu1 1Department of Clinical Laborator
Externí odkaz:
https://doaj.org/article/2981662515224d9da9104d81bd1417e0
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Treatment of carbapenem-resistant Enterobacterales (CRE) infections in low-resource settings is challenging particularly due to limited treatment options. Colistin is the mainstay drug for treatment; however, nephrotoxicity and ne
Externí odkaz:
https://doaj.org/article/d3ddb0434786410faac6e9b9ab005002
Autor:
Worapong Nasomsong, Chirakhana Siangtrong, Parnrada Nulsopapon, Supanun Pungcharoenkijkul, Patcharapa Boonmee, Wichai Santimaleeworagun
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 37, Iss , Pp 219-224 (2024)
ABSTRACT: Background: Biapenem (BIPM) exhibited a less efficient substrate for various metallo-β-lactamase (MBL) than other carbapenems. Objective: We aimed to evaluate in vitro susceptibility data of BIPM and optimal dose based on Monte Carlo simul
Externí odkaz:
https://doaj.org/article/8f6f3f2c70a441938666ddcb2227335c
Autor:
Heather N. Grome, Julian E. Grass, Nadezhda Duffy, Sandra N. Bulens, Uzma Ansari, Davina Campbell, Joseph D. Lutgring, Amy S. Gargis, Thao Masters, Alyssa G. Kent, Susannah L. McKay, Gillian Smith, Lucy E. Wilson, Elisabeth Vaeth, Bailey Evenson, Ghinwa Dumyati, Rebecca Tsay, Erin Phipps, Kristina Flores, Christopher D. Wilson, Christopher A. Czaja, Helen Johnston, Sarah J. Janelle, Ruth Lynfield, Sean O’Malley, Paula Snippes Vagnone, Meghan Maloney, Joelle Nadle, Alice Y. Guh
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 6, Pp 1104-1114 (2024)
We conducted surveillance for carbapenem-resistant Enterobacterales (CRE) during 2016–2020 at 10 US sites and extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E) during 2019–2020 at 6 US sites. Among 159 CRE cases in children (me
Externí odkaz:
https://doaj.org/article/788dc6e3489b4e2b9bd1e7608d1c7395